CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | -19.4% | 1,663 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $93 | +564.3% | 1,663 | +427.9% | 0.00% | – |
| Q1 2023 | $14 | +7.7% | 315 | 0.0% | 0.00% | – |
| Q4 2022 | $13 | -99.9% | 315 | +9.0% | 0.00% | – |
| Q3 2022 | $19,000 | +5.6% | 289 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | -85.0% | 289 | -84.9% | 0.00% | -100.0% |
| Q1 2022 | $120,000 | +14.3% | 1,913 | +38.3% | 0.00% | 0.0% |
| Q4 2021 | $105,000 | +12.9% | 1,383 | +65.6% | 0.00% | 0.0% |
| Q3 2021 | $93,000 | +287.5% | 835 | +460.4% | 0.00% | – |
| Q2 2021 | $24,000 | +33.3% | 149 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | -10.0% | 149 | +12.0% | 0.00% | – |
| Q4 2020 | $20,000 | -37.5% | 133 | -65.7% | 0.00% | – |
| Q3 2020 | $32,000 | 0.0% | 388 | +15.5% | 0.00% | -100.0% |
| Q2 2020 | $32,000 | +128.6% | 336 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | -26.3% | 336 | 0.0% | 0.00% | – |
| Q4 2019 | $19,000 | +35.7% | 336 | -3.4% | 0.00% | – |
| Q3 2019 | $14,000 | -12.5% | 348 | +4.8% | 0.00% | – |
| Q2 2019 | $16,000 | +33.3% | 332 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +71.4% | 332 | +30.7% | 0.00% | – |
| Q4 2018 | $7,000 | -36.4% | 254 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | -26.7% | 254 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | +25.0% | 254 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |